Hydroxocobalamin and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take Hydroxocobalamin (hydroxocobalamin), especially for people who are female, 40-49 old, also take Depakene, and have Dry eyes.

The phase IV clinical study analyzes which people have Erythema multiforme when taking Hydroxocobalamin. It is created by eHealthMe based on reports of 4,242 people who have side effects when taking Hydroxocobalamin from the FDA, and is updated regularly.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,707 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

On Jul, 10, 2026

4,242 people reported to have side effects when taking Hydroxocobalamin.
Among them, 13 people (0.31%) have Erythema multiforme.

Could Hydroxocobalamin cause Erythema multiforme?

Among these 13 people:

What is the gender of people who have Erythema multiforme when taking Hydroxocobalamin? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Erythema multiforme when taking Hydroxocobalamin? *

What are other drugs people take besides Hydroxocobalamin? *

What are other side effects people have besides Erythema multiforme? *

Rashes (redness): 3 people, 23.08%
Mouth Ulcers: 2 people, 15.38%
Type 1 Diabetes: 1 person, 7.69%
Lip Swelling: 1 person, 7.69%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 7.69%
Burning Sensation: 1 person, 7.69%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 1 person, 7.69%
Eye Swelling: 1 person, 7.69%
Eyelid Pain: 1 person, 7.69%
Fever: 1 person, 7.69%

What are the existing conditions these people have? *

Dry Eyes (lack of adequate tears): 4 people, 30.77%
Urinary Tract Infection: 3 people, 23.08%
Vitamin B12 Deficiency: 1 person, 7.69%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 7.69%
Rickets (softening of bones): 1 person, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 7.69%
Hypokalemia (low potassium): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydroxocobalamin:

Hydroxocobalamin (4,273 reports)

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythema multiforme:

Erythema multiforme (1,707 drugs)

Browse all the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,920 conditions)

Related publications that referenced our studies

Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.